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Abstract The mammalian period (Per) genes are components of
the circadian clock and appear to be regulated via an
autoregulatory feedback loop. Here we show that the human
PER1 (hPER1) gene is synergistically activated by protein
kinases A and C (PKA, PKC) and cAMP responsive element
binding protein. Activators and inhibitors of PKA as well as PKC
modulate endogenous hPER1 expression and hPER1 promoter-
driven reporter gene activity in a dose-dependent manner. Our
results suggest that the hPER1 promoter acts as a sensor for
multiple signaling molecules thereby integrating different phy-
siological parameters. This regulation of hPER1 appears to be
significant for rapid adaptation to changing environmental
conditions. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The circadian clock is a self-sustaining oscillator with a
periodicity of approximately 24 h and controls many physio-
logical and behavioral systems [1]. On the molecular level, the
oscillator consists of an autoregulatory feedback loop involv-
ing a set of clock genes (see [2]). Central components of the
mammalian circadian clock are the period (Per) genes which
are expressed in a diurnal manner in various tissues on the
RNA and protein levels [3^9] and also in cell culture [10].
Because the intrinsic circadian rhythm of an organism is not
exactly 24 h the clock needs to be reset periodically. Light
induces Per1 and Per2 gene expression [5,6,8,9,11]. In vitro,
rhythmic Per1 and Per2 expression is inducible by high serum
[10], forskolin [12,13] and phorbol 12-myristate 13-acetate
(PMA) [14]. In the SCN circadian regulation of gene expres-
sion can be mediated by cAMP analogs [15] through cAMP
response elements (CREs) [16]. Recent results indicate that
expression of Per1 is regulated in a species-dependent manner.
Alternative usage of promoter elements can elicit di¡erent
responses [17^19]. Since the read-outs of reporter gene assays
with hPER1^luciferase constructs depend on the promoter
fragment used [17^19], we compared endogenous activation
of hPER1, measured by quantitative PCR (TaqMan) analysis,
with hPER1^luc reporter gene assays in HUH-7 human hep-
atoma cells. Our results indicate that our reporter gene assay
re£ects endogenous hPER1 expression. Moreover, we found
that at least two independent signaling pathways are involved
in the acute induction of the human PER1 gene.
2. Materials and methods
2.1. Cell culture
Human hepatoma (HUH-7) cells were cultured in Dulbecco’s mini-
mum essential medium (MEM)/10% fetal calf serum (Biowhittacker),
penicillin/streptomycin (100 U/ml), and 2 mM L-glutamine at 37‡C in
a 5% CO2 atmosphere.
2.2. TaqMan analysis
500 000 cells per well were seeded in 6 well plates, preincubated
overnight and stimulated with 5,6-dichlorobenzimidazole-1-L-D-
ribofuranosyl-3P,5P-monophosphorothioate, Sp-isomer (Sp-5,6-DCl-
cBiMPS, 100 WM) and PMA (1 WM) in serum-free MEMK (Gibco)
for 2 h or left untreated. For RNA isolation and DNase treatment the
NucleoSpin RNA II Kit (Macherey-Nagel) was used. 2 Wg of RNA
was reverse transcribed using SuperScript II (Gibco) with 250 ng
random primer (Gibco). TaqMan PCR was carried out in a Perkin-
Elmer 7700 system in duplicate in a total volume of 25 Wl using Taq-
Man Universal PCR Master Mix (Applied Biosystems), 1 Wl cDNA
diluted 1/100, primers and probes (200 nM each). Thermocycling was
performed at 50‡C for 2 min, 95‡C for 10 min and 45 cycles between
95‡C for 15 s and 59‡C for 1 min. The quanti¢cation of PER1 was
done using two primers and a £uorescent probe covering parts of
exons 22 and 23. For normalization of template concentration primers
and probes for the housekeeping gene porphobilinogen deaminase
(PBGD) [20] were used. Resulting CT values of hPER1 ampli¢cation
were normalized to CT values of PBGD and analyzed according to the
vvCT method [21].
2.3. Construction of the hPER1 promoter luciferase reporter gene
construct
The hPER1 promoter was derived from the cosmid 39C2 [3]. A
3.7 kb HindIII fragment was subcloned into pBluescriptII SK(+)
and sequenced (GenBank accession number AF284444). A HindIII/
NcoI fragment was ligated into the promoterless pGL2 vector (Prom-
ega). The fragment comprises the sequence from position 31347 to
+1317 relative to the putative transcription start site [18] and will be
referred to as hPER1^luc.
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2.4. Transfection, stimulation and luciferase reporter gene assays
Transfection was done according to the supplier’s instructions (Qia-
gen). 40 000 cells per well were plated onto 96 whitewell plates (Co-
star), incubated for 16 h and stimulated for 4 h in 25 Wl total volume.
Inhibitors were preincubated for 20 min. Then 25 Wl Steady Glo so-
lution (Promega) per well was added and the cells were lysed for 20
min by shaking at 250 U/min. Light emission was measured in a
luminometer (Lumistar, BMG).
2.5. Immunoblot analysis
The cells were left untreated or treated for 1 h with Sp-5,6-DCl-
cBiMPS (100 WM), PMA (30 nM) alone or in combination. The cells
were lysed, electrophoresed and blotted as described [22]. Membranes
were incubated with antisera against pCREB, CREB, pMAPK42/44
or MAPK42/44 (1:2000, New England BioLabs, Beverly, MA, USA)
overnight at 4‡C. Signals were detected as described [22].
2.6. Statistics
Data were analyzed using MS Excel and GraphPad Prism (3.0 for
Windows; GraphPad Prism Software Inc., San Diego, CA, USA).
Data are expressed as the means ( þ S.D.) and were compared using
ANOVA with subsequent Bonferroni tests for multiple comparisons
or Student’s t-test, with P6 0.05 as the criterion of signi¢cance.
3. Results
We ¢rst tested the inducibility of the hPER1^luc reporter
construct by forskolin, a known inducer of circadian Per1
expression [13]. Forskolin led to a concentration-dependent
induction of the hPER1 reporter gene activity in HUH-7 hu-
man hepatoma cells (Fig. 1A). This was comparable to the
induction observed in rat-1 ¢broblasts [13] indicating that the
human PER1 promoter responds in a similar fashion to for-
skolin as the rat Per1 promoter.
Forskolin elevates cAMP levels in the cell. Therefore we
tested whether the cell-permeable and PKA-speci¢c cAMP
analog Sp-5,6-DCl-cBiMPS [23] could activate the human
PER1 promoter. Fig. 1B (control) shows that this is the
case. Also the protein kinase C (PKC) inducer PMA led to
a signi¢cant increase of hPER1^luc activity (Fig. 1B). When
PMA was applied in increasing concentrations together with
di¡erent amounts of Sp-5,6-DCl-cBiMPS (3, 10 and 30 WM)
the hPER1^luc activity was potentiated (Fig. 1B). To test
whether the endogenous human PER1 promoter is stimulated
in a similar manner, we performed TaqMan PCR analysis for
relative quanti¢cation of endogenous hPER1 expression. The
mRNA level of hPER1 was elevated 2.25 ( þ 0.25 S.D.) fold
after stimulation with Sp-5,6-DCl-cBiMPS/PMA (Fig. 2),
which is comparable to the induction of the hPER1^luc re-
Fig. 1. Induction of hPER1^luc in HUH-7 human hepatoma cells.
A: Dose-dependent stimulation of hPER1^luc by forskolin (n = 8).
B: Dose^response curve of hPER1^luc activation by the phorbol es-
ter PMA alone or in combination with increasing amounts of the
protein kinase A (PKA) activator Sp-5,6-DCl-cBiMPS (Sp-5,6-DCl-
cBiMPS alone = control) (n = 6). Statistical signi¢cance was calcu-
lated by ANOVA with Bonferroni post test relative to the control
values with *P6 0.05, ***P6 0.001.
Fig. 2. Relative quanti¢cation of hPER1 and PBGD after stimula-
tion with Sp-5,6-DCl-cBiMPS (100 WM) and PMA (1 WM) for 2 h.
Endogenous hPER1 expression in HUH-7 cells is induced
2.25 þ 0.25 fold whereas PBGD is not induced. Results show the
mean of ¢ve independent experiments þ S.D. Statistical signi¢cance
was calculated by Student’s t-test, *P6 0.001.
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porter in our assay. This indicates that the endogenous pro-
moter responds in a similar fashion as the reporter construct.
The next question we addressed was whether this induction
of hPER1^luc activity via the PKA/PKC pathway is inhibited
by 8-(4-chlorophenylthio)adenosine-3P,5P-cyclic monophos-
phorothioate, Rp-isomer (Rp-8-CPT-cAMPS), a PKA inhibi-
tor [24], and chelerythrin, a PKC inhibitor. The cells were
treated with either one of the inhibitors alone, or in combi-
nation. Then the cells were stimulated with Sp-5,6-DCl-
cBiMPS/PMA (Fig. 3). The PKA inhibitor completely
blocked the Sp-5,6-DCl-cBiMPS/PMA-mediated induction at
1 mM. Chelerythrin, however, inhibited 40% of the hPER1^
luc activity at 1 WM. There was no additional reduction if Rp-
8-CPT-cAMPS and chelerythrin were added simultaneously
compared to Rp-8-CPT-cAMPS treatment alone (Fig. 3).
Both chelerythrin and Rp-8-CPT-cAMPS inhibited the
hPER1^luc activity in a dose-dependent fashion (data not
shown). Next we studied hPER1^luc induction in the presence
of killer-CREB (K-CREB); [25] and A-CREB [26], two dom-
inant-negative mutated forms of the transcription factor
cAMP responsive element binding protein (CREB). Both A-
CREB and K-CREB inhibited the Sp-5,6-DCl-cBiMPS-medi-
ated e¡ect, but did not in£uence the PMA-mediated hPER1^
luc induction (Fig. 4). However, A-CREB also considerably
reduced the basal expression of hPER1^luc in comparison to
control and K-CREB-cotransfected cells (Fig. 4).
Next we investigated whether PKA and PKC pathways can
induce CREB phosphorylation in HUH-7 cells. When treated
with Sp-5,6-DCl-cBiMPS or Sp-5,6-DCl-cBiMPS/PMA an in-
creased amount of pCREB in comparison to control or PMA-
stimulated cells was observed (Fig. 5). As expected PMA (30
nM) also increased the levels of pMAPK42/44 (Fig. 5). In
contrast, Sp-5,6-DCl-cBiMPS treatment inhibited both basal
and PMA-induced pMAPK42/44 activity.
4. Discussion
Recent reports [17^19] imply a high organizational com-
plexity of Per1 expression, e.g. murine Per1 possesses two
alternative promoters. Our data show that endogenous
hPER1 mRNA in HUH-7 cells is signi¢cantly elevated by
stimulation with Sp-5,6-DCl-cBiMPS/PMA. To investigate
the signal transduction pathway leading to hPER1 expression
a hPER1^luciferase promoter construct was designed which
Fig. 3. E¡ect of PKA and PKC inhibitors on hPER1^luc activity in
HUH-7 cells treated with PKA (Sp-5,6-DCl-cBiMPS) and PKC
(PMA) activators. Cells were left untreated (Co) or treated with
Sp-5,6-DCl-cBiMPS/PMA (Sp+PMA; 30 WM+300 nM) alone or to-
gether with either PKC inhibitor chelerythrin (1 WM), the PKA in-
hibitor Rp-8-CPT-cAMPS (1 mM) or both. Statistical signi¢cance
was calculated by ANOVA with Bonferroni post test relative to the
control value (Co) with ***P6 0.001 and n = 6.
Fig. 4. Reduction of Sp-5,6-DCl-cBiMPS/PMA-stimulated hPER1^
luc activity in cells cotransfected with CREB inhibitors. A: Cotrans-
fection of the hPER1^luc construct with pGL2-basic. Sp-5,6-DCl-
cBiMPS (30 WM), PMA (100 nM) and the combination of both
showed increased hPER1^luc activity. B: Cotransfection of the
hPER1^luc construct with A-CREB. C: Cotransfection of the
hPER1^luc construct with K-CREB. hPER1^luc activity in
A-CREB- and K-CREB-cotransfected cells was no longer inducible
by Sp-5,6-DCl-cBiMPS. The PMA response was still present in
the A-CREB- and K-CREB-transfected cells (B,C). Shown are the
means þ S.D. of four experiments; *P6 0.05; **P6 0.01;
***P6 0.001. Statistical signi¢cance was calculated by ANOVA
with Bonferroni post test relative to the control values.
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re£ects the endogenous stimulation in this particular system,
the HUH-7 human hepatoma cell line.
Forskolin induces circadian gene expression of Per1 in rat-1
¢broblasts [13] and also in ovine pars tuberalis cells [12]. Our
data show that application of forskolin to hPER1^luc-trans-
fected HUH-7 cells results in an induction of luciferase activ-
ity. Forskolin activates adenylate cyclase, enhances the syn-
thesis of cAMP and results in activation of PKA. This is in
agreement with the notion that a cAMP-mediated mechanism
is important for the phase resetting of the central circadian
rhythm in the SCN [27^29]. Accordingly the cAMP analog
Sp-5,6-DCl-cBiMPS induces hPER1^luc activity in a dose-de-
pendent manner. However, the hPER1 promoter is not exclu-
sively activated through the PKA pathway. The PKC activa-
tor PMA leads to an induction of hPER1^luc in a dose-
dependent manner in HUH-7 cells, whereas in sheep pars
tuberalis cells PMA did not induce Per1 gene expression
[12]. This indicates that the PKC signaling pathway can con-
tribute to the activation of the hPER1 promoter in hepatoma
cells. Interestingly, coapplication of PMA and Sp-5,6-DCl-
cBiMPS elicits a potentiation of the hPER1 promoter activity.
This suggests that coincidental extracellular events can poten-
tiate hPER1 induction which in turn might in£uence the
strength of behavioral responses of an organism to environ-
mental changes [29].
To dissect the contributions of the PKA and PKC path-
ways we looked at phosphorylation events. In HUH-7 cells
CREB phosphorylation is primarily stimulated via the PKA
pathway whereas MAPK phosphorylation is stimulated via
the PKC pathway.
Although coapplication of Sp-5,6-DCl-cBiMPS and PMA
leads to a lower elevation of pMAPK in comparison to PMA
alone, both the reporter gene activity and the endogenous
expression of hPER1 were potentiated. Therefore, we con-
clude that MAPK phosphorylation seems to be of minor im-
portance. The potentiation of reporter gene activation is prob-
ably assisted by additional signaling components as suggested
by others [29^31].
As expected, pharmacological inhibitors speci¢c for block-
ing the PKA and the PKC pathways prevented induction of
hPER1^luc. Similarly, cotransfected mutated forms of CREB
(A-CREB and K-CREB) inhibited stimulated hPER1^luc re-
porter activity. However, both CREB antagonists did not in-
hibit the PMA-stimulated reporter gene activity. This suggests
that the PMA stimulation of hPER1^luc activity is not medi-
ated by CREB phosphorylation. This is in agreement with the
immunoblot results (Fig. 5).
The basal expression of hPER1^luc was considerably re-
duced by A-CREB cotransfection. This could be due to the
fact that A-CREB irreversibly binds most of the endogenous
CREB present in the cell [26]. The consequence would be that
even housekeeping functions are a¡ected causing a reduced
responsiveness of the cell to various stimuli. Thus PKA/
PKC coactivation is partly mediated via pCREB but probably
needs additional unknown regulators, such as protein phos-
phatases [32] or transcription factors [30]. Our data suggest
that the hPER1^luc is context-sensitive reminiscent of the
LAP/C/EBP promoter in HUH-7 cells and liver [33].
In conclusion, we show here that extracellular stimulators
acting through the PKA and PKC pathways regulate the hu-
man PER1 promoter in HUH-7 cells. These pathways have
previously been shown to reset the circadian clock
[14,27,29,34^36]. Most importantly, rapid circadian induction
of Per genes in cell cultures is independent of protein synthesis
[10]. We provide evidence that rapid Per gene activation is
probably achieved at least in part by phosphorylation of com-
ponents of classical signaling pathways. It might be speculated
that the well established autoregulatory feedback mechanism
for Per1 is modulated by second messenger pathways. Thus
the Per1 promoter may serve as a sensor and integrator of
physiological changes in an organism in order to adjust the
clock to environmental challenges.
Acknowledgements: This work was supported by grants from the
Deutsche Forschungsgemeinschaft to U.A. (Al 549/1-1) and E.M.
(MA 2277/2-1). We thank G. Eichele, K. Adermann and M. Meyer
for generous support, C. Vinson for A-CREB, and J. Stehle for
K-CREB gifts.
References
[1] Ascho¡, J. (1981) Handbook of behavioral neurobiology, Vol. 4
(Ascho¡, J., Ed.), Plenum, New York.
[2] Dunlap, J.C. (1999) Cell 96, 271^290.
[3] Sun, Z.S., Albrecht, U., Zhuchenko, O., Bailey, J., Eichele, G.
and Lee, C.C. (1997) Cell 90, 1003^1011.
[4] Tei, H., Okamura, H., Shigeyoshi, Y., Fukuhara, C., Ozawa, R.,
Hirose, M. and Sakaki, Y. (1997) Nature 389, 512^516.
[5] Albrecht, U., Sun, Z.S., Eichele, G. and Lee, C.C. (1997) Cell 91,
1055^1064.
[6] Shearman, L.P., Zylka, M.J., Weaver, D.R., Kolakowski, L.F.
and Reppert, S.M. (1997) Neuron 19, 1261^1269.
[7] Zylka, M.J., Shearman, L.P., Weaver, D.P. and Reppert, S.M.
(1998) Neuron 20, 1103^1110.
[8] Takumi, T. et al. (1998) Genes Cells 3, 167^176.
[9] Field, M.D., Maywood, E.S., O’Brien, J.A., Weaver, D.R., Rep-
pert, S.M. and Hastings, M.H. (2000) Neuron 25, 437^447.
[10] Balsalobre, A., Damiola, F. and Schibler, U. (1998) Cell 93, 929^
937.
[11] Shigeyoshi, Y. et al. (1997) Cell 91, 1043^1053.
[12] Morgan, P.J., Ross, A.W., Graham, E.S., Adam, C., Messager,
S. and Barrett, P. (1998) J. Neuroendocrinol. 10, 319^323.
[13] Yagita, K. and Okamura, H. (2000) FEBS Lett. 465, 79^82.
[14] Akashi, M. and Nishida, E. (2000) Genes Dev. 14, 645^649.
[15] Gillette, M.U. (1996) Prog. Brain Res. 111, 121^132.
[16] Obrietan, K., Impey, S., Smith, D., Athos, J. and Storm, D.R.
(1999) J. Biol. Chem. 274, 17748^17756.
[17] Hida, A., Koike, N., Hirose, M., Hattori, M., Sakaki, Y. and
Tei, H. (2000) Genomics 65, 224^233.
Fig. 5. Induction of CREB phosphorylation in human HUH-7 hep-
atoma cells treated for 1 h with the indicated agents. The antigen
detected is shown on the left. As illustrated by the horizontal black
bars on top, each experiment was carried out in triplicate.
FEBS 24407 11-12-00
D. Motzkus et al./FEBS Letters 486 (2000) 315^319318
[18] Taruscio, D., Zoraqi, G.K., Falchi, M., Iosi, F., Paradisi, S., Di
Fiore, B., Lavia, P. and Falbo, V. (2000) Gene 253, 161^170.
[19] Yamaguchi, S. et al. (2000) Curr. Biol. 10, 873^876.
[20] Cassinat, B. et al. (2000) Leukemia 14, 324^328.
[21] Winer, J., Jung, C.K., Shackel, I. and Williams, P.M. (1999)
Anal. Biochem. 270, 41^49.
[22] Maronde, E., Wicht, H., Tasken, K., Genieser, H.-G., Dehghani,
F., Olcese, J. and Korf, H.-W. (1999) J. Pineal Res. 27, 170^182.
[23] Sandberg, M. et al. (1991) Biochem. J. 279, 521^527.
[24] Gjertsen, B.T. et al. (1995) J. Biol. Chem. 270, 20599^20607.
[25] Walton, K.M., Rehfuss, R.P., Chrivia, J.C., Lochner, J.E. and
Goodman, R.H. (1992) Mol. Endocrinol. 6, 647^655.
[26] Ahn, S., Olive, M., Aggarwal, S., Krylov, D., Ginty, D.D. and
Vinson, C. (1998) Mol. Cell. Biol. 18, 967^977.
[27] Prosser, R.A. and Gillette, M.U. (1989) J. Neurosci. 9, 1073^
1081.
[28] Ding, J.M., Faiman, L.E., Hurst, W.J., Kuriashkina, L.R. and
Gillette, M.U. (1997) J. Neurosci. 17, 667^675.
[29] Tischkau, S.A., Gallman, E.A., Buchanan, G.F. and Gillette,
M.U. (2000) J. Neurosci. 20, 7830^7837.
[30] Pohnke, Y., Kempf, R. and Gellersen, B. (1999) J. Biol. Chem.
274, 24808^24818.
[31] Schumann, G., Huell, M., Machein, U., Hocke, G. and Fiebich,
B.L. (1999) J. Neurochem. 73, 2009^2017.
[32] Hagiwara, M. et al. (1992) Cell 70, 105^113.
[33] Niehof, M., Manns, M.P. and Trautwein, C. (1997) Mol. Cell.
Biol. 17, 3600^3613.
[34] Schak, K.M. and Harrington, M.E. (1999) Brain Res. 840, 158^
161.
[35] Lee, J.M., Schak, K.M. and Harrington, M.E. (1999) Brain Res.
835, 350^353.
[36] Sanada, K., Hayashi, Y., Harada, Y., Okano, T. and Fukada, Y.
(2000) J. Neurosci. 20, 986^991.
FEBS 24407 11-12-00
D. Motzkus et al./FEBS Letters 486 (2000) 315^319 319
